Association of white matter deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized VBM study using 3T

2013 ◽  
Vol 27 (4) ◽  
pp. 283-290 ◽  
Author(s):  
Li Yao ◽  
Su Lui ◽  
Wei Deng ◽  
Min Wu ◽  
Lizhou Chen ◽  
...  
Keyword(s):  
White Matter ◽  
Clinical Symptoms ◽  
First Episode ◽  
First Episode Schizophrenia

White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment

2013 ◽  
Vol 43 (11) ◽  
pp. 2301-2309 ◽  
Author(s):  
Q. Wang ◽  
C. Cheung ◽  
W. Deng ◽  
M. Li ◽  
C. Huang ◽  
...  
Keyword(s):  
White Matter ◽  
Early Phase ◽  
Clinical Symptoms ◽  
Diffusion Tensor ◽  
Disease Process ◽  
Anterior Cingulate ◽  
First Episode ◽  
Drug Naïve ◽  
The Right ◽  
First Episode Schizophrenia

BackgroundIt is not clear whether the progressive changes in brain microstructural deficits documented in previous longitudinal magnetic resonance imaging (MRI) studies might be due to the disease process or to other factors such as medication. It is important to explore the longitudinal alterations in white-matter (WM) microstructure in antipsychotic-naive patients with first-episode schizophrenia during the very early phase of treatment when relatively ‘free’ from chronicity.MethodThirty-five patients with first-episode schizophrenia and 22 healthy volunteers were recruited. High-resolution diffusion tensor imaging (DTI) was obtained from participants at baseline and after 6 weeks of treatment. A ‘difference map’ for each individual was calculated from the 6-week follow-up fractional anisotropy (FA) of DTI minus the baseline FA. Differences in Positive and Negative Syndrome Scale (PANSS) scores and Global Assessment of Functioning (GAF) scores between baseline and 6 weeks were also evaluated and expressed as a 6-week/baseline ratio.ResultsCompared to healthy controls, there was a significant decrease in absolute FA of WM around the bilateral anterior cingulate gyrus and the right anterior corona radiata of the frontal lobe in first-episode drug-naive patients with schizophrenia following 6 weeks of treatment. Clinical symptoms improved during this period but the change in FA did not correlate with the changes in clinical symptoms or the dose of antipsychotic medication.ConclusionsDuring the early phase of treatment, there is an acute reduction in WM FA that may be due to the effects of antipsychotic medications. However, it is not possible to entirely exclude the effects of underlying progression of illness.

Extensive White Matter Abnormalities and Clinical Symptoms in Drug-Naive Patients With First-Episode Schizophrenia

2015 ◽  
Vol 77 (02) ◽  
pp. 205-211 ◽  
Author(s):  
Xiang Yang Zhang ◽  
Feng-Mei Fan ◽  
Da-Chun Chen ◽  
Yun-Long Tan ◽  
Shu-Ping Tan ◽  
...  
Keyword(s):  
White Matter ◽  
Clinical Symptoms ◽  
First Episode ◽  
White Matter Abnormalities ◽  
Drug Naïve ◽  
First Episode Schizophrenia

Pretreatment abnormalities in white matter integrity predict one-year clinical outcome in first episode schizophrenia

2021 ◽  
Vol 228 ◽  
pp. 241-248
Author(s):  
Jiaxin Zeng ◽  
Wenjing Zhang ◽  
Yuan Xiao ◽  
Gui Fu ◽  
Lu Liu ◽  
...  
Keyword(s):  
White Matter ◽  
Clinical Outcome ◽  
White Matter Integrity ◽  
First Episode ◽  
One Year ◽  
First Episode Schizophrenia

White matter microstructure in ultra-high risk and first episode schizophrenia: A prospective study

2016 ◽  
Vol 247 ◽  
pp. 42-48 ◽  
Author(s):  
Silvia Rigucci ◽  
Giulia Santi ◽  
Valentina Corigliano ◽  
Annamaria Imola ◽  
Camilla Rossi-Espagnet ◽  
...  
Keyword(s):  
White Matter ◽  
High Risk ◽  
Prospective Study ◽  
First Episode ◽  
White Matter Microstructure ◽  
Ultra High Risk ◽  
A Prospective Study ◽  
First Episode Schizophrenia

scholarly journals Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory

2011 ◽  
Vol 132 (1) ◽  
pp. 35-41 ◽  
Author(s):  
George Bartzokis ◽  
Po H. Lu ◽  
Chetan P. Amar ◽  
Erika P. Raven ◽  
Nicole R. Detore ◽  
...  
Keyword(s):  
White Matter ◽  
First Episode ◽  
Differential Impact ◽  
Oral Risperidone ◽  
Long Acting ◽  
First Episode Schizophrenia

scholarly journals White-matter free-water diffusion MRI in schizophrenia: a systematic review and meta-analysis

2022 ◽  
Author(s):  
Inês Carreira Figueiredo ◽  
Faith Borgan ◽  
Ofer Pasternak ◽  
Federico E. Turkheimer ◽  
Oliver D. Howes
Keyword(s):  
White Matter ◽  
Healthy Volunteers ◽  
Diffusion Mri ◽  
Clinical Symptoms ◽  
Free Water ◽  
Brain Regions ◽  
Water Levels ◽  
First Episode ◽  
Whole Brain ◽  
Illness Duration

AbstractWhite-matter abnormalities, including increases in extracellular free-water, are implicated in the pathophysiology of schizophrenia. Recent advances in diffusion magnetic resonance imaging (MRI) enable free-water levels to be indexed. However, the brain levels in patients with schizophrenia have not yet been systematically investigated. We aimed to meta-analyse white-matter free-water levels in patients with schizophrenia compared to healthy volunteers. We performed a literature search in EMBASE, MEDLINE, and PsycINFO databases. Diffusion MRI studies reporting free-water in patients with schizophrenia compared to healthy controls were included. We investigated the effect of demographic variables, illness duration, chlorpromazine equivalents of antipsychotic medication, type of scanner, and clinical symptoms severity on free-water measures. Ten studies, including five of first episode of psychosis have investigated free-water levels in schizophrenia, with significantly higher levels reported in whole-brain and specific brain regions (including corona radiata, internal capsule, superior and inferior longitudinal fasciculus, cingulum bundle, and corpus callosum). Six studies, including a total of 614 participants met the inclusion criteria for quantitative analysis. Whole-brain free-water levels were significantly higher in patients relative to healthy volunteers (Hedge’s g = 0.38, 95% confidence interval (CI) 0.07–0.69, p = 0.02). Sex moderated this effect, such that smaller effects were seen in samples with more females (z = −2.54, p < 0.05), but antipsychotic dose, illness duration and symptom severity did not. Patients with schizophrenia have increased free-water compared to healthy volunteers. Future studies are necessary to determine the pathological sources of increased free-water, and its relationship with illness duration and severity.

scholarly journals Abnormalities of EEG Microstates In Drug-Naïve, First-Episode Schizophrenia

2021 ◽  
Author(s):  
Qiaoling Sun ◽  
Linlin Zhao ◽  
Liwen Tan
Keyword(s):  
Clinical Symptoms ◽  
Early Stage ◽  
First Episode ◽  
Healthy Controls ◽  
Brain Functions ◽  
Class D ◽  
Syndrome Scale ◽  
Drug Naïve ◽  
Microstate Analysis ◽  
First Episode Schizophrenia

Abstract Objective: Microstate analysis is a powerful tool to probe the brain functions, and changes in microstates under electroencephalography (EEG) have been repeatedly reported in patients with schizophrenia. This study aimed to investigate the dynamics of EEG microstates in drug-naïve, first-episode schizophrenia (FE-SCH) and to test the relationship between EEG microstates and clinical symptoms.Methods: Resting-state EEG were recorded for 23 patients with FE-SCH and 23 healthy controls using a 64-channel cap. Three parameters, i.e., contribution, duration, and occurrence, of the four microstate classes were calculated. Group differences in EEG microstates and their clinical symptoms (assessed using the Positive and Negative Syndrome Scale) were analyzed.Results: Compared with healthy controls, patients with FE-SCH showed increased duration, occurrence and contribution of microstate class C and decreased contribution and occurrence of microstate class D. In addition, the score of positive symptoms in PANSS was negatively correlated with the occurrence of microstate D.Conclusions: Our findings showed abnormal patterns of EEG microstates in drug-naïve, first-episode schizophrenia, which might help distinguish individuals with schizophrenia in the early stage and develop early intervention strategies.

scholarly journals Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Mi Yang ◽  
Shan Gao ◽  
Xiangyang Zhang
Keyword(s):  
Cognitive Impairment ◽  
White Matter ◽  
Diffusion Tensor ◽  
Internal Capsule ◽  
First Episode ◽  
Control Group ◽  
Pathophysiological Mechanism ◽  
Healthy Controls ◽  
Healthy Control ◽  
First Episode Schizophrenia

Abstract Cognitive impairment is viewed as a core symptom of schizophrenia (SCZ), but its pathophysiological mechanism remains unclear. White matter (WM) disruption is considered to be a central abnormality that may contribute to cognitive impairment in SCZ patients. However, few studies have addressed the association between cognition and WM integrity in never-treated first-episode (NTFE) patients with SCZ. In this study, we used the MATRICS Consensus Cognitive Battery (MCCB) to evaluate cognitive function in NTFE patients (n = 39) and healthy controls (n = 30), and associated it with whole-brain fractional anisotropy (FA) values obtained via voxel-based diffusion tensor imaging. We found that FA was lower in five brain areas of SCZ patients, including the cingulate gyrus, internal capsule, corpus callosum, cerebellum, and brainstem. Compared with the healthy control group, the MCCB’s total score and 8 out of 10 subscores were significantly lower in NTFE patients (all p < 0.001). Moreover, in patients but not healthy controls, the performance in the Trail Making Test was negatively correlated with the FA value in the left cingulate. Our findings provide evidence that WM disconnection is involved in some cognitive impairment in the early course of SCZ.

Sign in / Sign up

Export Citation Format

Share Document